4 results about "Beta-Alanine" patented technology

A solid supplement composition comprising at least one non-ester nitrate compound and at least one isolated amino acid compound, wherein the at least one isolated amino acid compound is beta alanine, wherein the at least one isolated amino acid compound is a separate compound than the at least one non-ester nitrate compound, and wherein the solid supplement composition comprises an amount of nitrate ion (NO3−) that is at least about 1 mg. A semisolid supplement composition comprising at least one non-ester nitrate compound and at least one isolated amino acid compound, wherein the at least one isolated amino acid compound is beta alanine, wherein the at least one isolated amino acid compound is a separate compound than the at least one non-ester nitrate compound, and wherein the semisolid supplement composition comprises an amount of nitrate ion (NO3−) that is at least about 1 mg.

A pre-workout lollipop composition for enhancing workout performance and supporting muscle function and recovery is disclosed. The lollipop is a unique blend of essential pre-workout ingredients, comprising 1.5 weight percentage caffeine anhydrous, 10 weight percentage beta alanine, 0.05 weight percentage vitamins B6 and B12, 50 weight percentage mixture of corn syrup and brown rice syrup, 15 weight percentage L-citrulline, 1.5 weight percentage electrolytes, and 22 weight percentage natural flavors and sweeteners. The lollipop is consumed about 30 minutes before physical activity, offering a convenient and effective supplement solution. In one embodiment, the ingredients are combined into a syrup base, mixed uniformly, and then poured into molds to form the lollipops. This innovative delivery system provides rapid absorption of ingredients in the mouth and stomach, enhancing alertness, endurance, and overall workout performance.

An anti-anxiety composition includes 2 grams of Beta Alanine; 0.75 grams of agmatine sulfate; 0.75 grams of taurine; 0.75 grams of magnesium citrate; and 100 mg of l-theanine. A method for decreasing anxiety in a subject includes administering to the subject a drinkable liquid that includes 0.25-2 grams of Beta Alanine.

Provided herein are methods of treating conditions associated with activation or over-activation of mast cells is acute or chronic urticaria, mastocytosis or any subtype of mastocytosis, pseudo-allergy, any form of dermatitis, such as contact or atopic dermatitis, wound healing, rosacea, acne, or psoriasis, food allergy, or irritable bowel syndrome. The method comprises administering a MRGPRD agonist, such as beta alanine, GABA, β-AIBA, or 5-oxoETE to a patient to treat the condition. Topical, enteric, delayed-release, or aerosol dosage forms comprising beta-alanine also are provided.